FrancophonIA/ELRC3.0 huggingface dataset:
English: Caution is adviced during cotreatment with carbamazepin (a CYP3A substrate) and lansoprazole.
Swedish: Karbamazepin Försiktighet bör iakttas vid samtidig behandling med karbamazepin (ett CYP3A-substrat) och lansoprazol.
English: The effect may also be present if lansoprazole is combined with other drugs with pH dependent absorption.
Swedish: Effekten kan också uppstå om lansoprazol kombineras med andra läkemedel vars absorption påverkas av pH-värdet.
English: Increase in cholesterol and triglyceride levels.
Swedish: Undersökningar förhöjda halter av kolesterol och triglycerider
English: Lansoprazole may give rise to increased plasma concentrations of drugs metabolised by CYP3A4.
Swedish: Lansoprazol kan höja plasmakoncentrationen av läkemedel som metaboliseras av CYP3A4.
English: Fluvoxamine, an inhibitor of CYP2C19, increased the plasma concentrations of lansoprazole up to 4-fold.
Swedish: Fluvoxamin, en hämmare av CYP2C19, höjde plasmakoncentrationerna av lansoprazol upp till 4 gånger.
English: Opaque, yellow hard gelatine capsule, containing pellets with enteric coating.
Swedish: Ogenomskinlig, gul, hård gelatinkapsel som innehåller pelletar med enterodragering.
English: Drugs which inhibit CYP2C19 may increase the plasma concentration of lansoprazole.
Swedish: Läkemedel som hämmar CYP2C19 kan höja plasmakoncentrationen av lansoprazol.
English: Benefit/Risk considerations Available data support the use of lansoprazole-amoxicillin-clarithromycin as a first-line treatment.
Swedish: Tillgängliga data stöder användningen av lansoprazol-amoxicillin-klaritromycin som förstahandsval vid behandling.
English: Special Warning and Precautions for Use The diagnosis of gastroduodenal ulcers and reflux oesophagitis should be confirmed by endoscopy or other appropriate diagnostic means.
Swedish: Diagnoserna ventrikel-/duodenalsår och refluxesofagit skall bekräftas med endoskopi eller andra lämpliga diagnostiska metoder.
English: Metabolism and elimination: The metabolism of lansoprazole is mainly catalysed by the enzyme CYP2C19.
Swedish: Metabolismen av lansoprazol katalyseras huvudsakligen av enzymet CYP2C19.
English: Pharmacodynamic Properties
Swedish: Farmakodynamiska egenskaper
English: 30 mg inhibits pentagastrin-stimulated gastric acid secretion by about 80%.
Swedish: En peroral engångsdos om 30 mg lansoprazol hämmar pentagastrinstimulerad sekretion av magsyra med ca 80 %.
English: (See Section 4.2 “
Swedish: (Se avsnitt 4.2 ”Dosering och administreringssätt”.)
English: Whereas, The scope of the referral was to agree on a Summary of Products Characteristics in view of the posology for eradication therapy for H. pylori
Swedish: Syftet med hänskjutningsförfarandet var att nå enighet om en produktresumé med tanke på doseringen vid eradikeringsbehandling mot Helicobacter pylori.
English: MARKETING AUTHORISATION HOLDER [To be completed nationally]
Swedish: INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING [Fylls i lokalt]
English: Caution and increased monitoring frequency is advised when initiating or ending lansoprazole co treatment in patients treated with warfarin.
Swedish: Försiktighet och tätare kontroller rekommenderas vid in- respektive utsättande av lansoprazol hos patienter som samtidigt behandlas med warfarin.
English: Incompatibilities Not applicable
Swedish: Inkompatibiliteter
English: Monitoring of tacrolimus plasma concentrations is advised when concomitant treatment with lanzoprazole is initiated or ended.
Swedish: Kontroll av plasmakoncentrationerna av takrolimus rekommenderas vid in respektive utsättande av samtidig behandling med lansoprazol.
English: Nervous system headache, dizziness restlessness, insomnia, drowsiness, depression, hallucination, confusion, vertigo and paresthesia, somnolence, tremor.
Swedish: depression, hallucinationer, konfusion, svindel och parestesi, somnolens, tremor
English: clarithromycin (C) and amoxycillin (A) (PCA) vs. those using proton pump inhibitor, clarithromycin and a nitroimidazole (N) (PCN) for H. pylori eradication provided evidence in support of similar H. pylori eradication efficacy.
Swedish: En metaanalys av studier där man jämförde trippelbehandling, två gånger dagligen under en vecka med en protonpumpshämmare, klaritromycin (C) och amoxycillin (A) (PCA), med användning av protonpumpshämmare, klaritromycin och en nitromidazol (N) (PCN) för eradikering av Helicobacter pylori gav stödjande bevis för likvärdig effekt av Helicobacter pylori-eradikering.
English: Three metabolites have been identified in the urine: 5-hydroxy sulphone, 5
Swedish: Tre metaboliter har identifierats i urinen: 5-hydroxisulfon, 5-hydroxisulfid och 5-hydroxilansoprazol.
English: In mice dose-related gastric ECL cell hyperplasia developed as well as liver tumours and adenoma of rete testis.
Swedish: Hos mus utvecklades dosrelaterad hyperplasi av ECL-celler i ventrikeln liksom levertumörer och adenom i rete testis.
English: Posology and Method of Administration
Swedish: Dosering och administreringssätt
English: The ulcer usually heals within 4 weeks, but in patients not fully healed within this time, the medication should be continued at the same dose for another 4 weeks.
Swedish: Såret läker normalt inom 4 veckor men om det inte har läkt helt inom denna tid, skall medicineringen fortsättas med samma dos i ytterligare
English: Lansopon 15 mg, 30 mg, gastro-resistant capsules, hard were referred for arbitration according to Article 29 of Council Directive 2001/83/EC, as amended, following concerns raised by Germany during a Mutual Recognition Procedure with Finland acting as Reference Member state.
Swedish: 2001/83/EG, i dess ändrade lydelse, som en följd av frågor som Tyskland tagit upp i samband med ett förfarande för ömsesidigt erkännande med Finland som referensmedlemsstat.
English: Drugs metabolised by CYP3A4
Swedish: Läkemedel som metaboliseras av CYP3A4
English: In patients not fully healed within this time, the medication should be continued at the same dose for another two weeks.
Swedish: Hos patienter vars sår inte har läkt helt inom denna tid skall medicineringen fortsättas med samma dos i ytterligare två veckor.
English: Instructions for Use and Handling No special requirements.
Swedish: Inga särskilda anvisningar.
English: Aluminium/Aluminium blister (Alu/OPA/PVC/PE)
Swedish: Förpackningstyp och innehåll Aluminium/Aluminiumblister (Alu/OPA/PVC/PE) Lansoprazol 15 mg:
English: The recommended dose is 30 mg once daily for 4 weeks.
Swedish: Den rekommenderade dosen är 30 mg en gång om dagen i 4 veckor.
English: Preclinical Safety Data
Swedish: Prekliniska säkerhetsuppgifter
English: fever, hyperhidrosis,
Swedish: Allmänna symtom trötthet feber, hyperhidros,
English: mg twice daily was associated with eradication rates ranging from 71 to 94%, and ulcer healing rates were generally >80% in well designed studies.
Swedish: Lansoprazol 30 mg kombinerat med amoxicillin 1g, klaritromycin 250 eller 500 mg, eller metronidazol 400 mg två gånger dagligen ledde till eradikeringsnivåer på mellan 71 och 94 %, och läkningsfrekvensen för sår var i allmänhet >80 % i väl utformade studier.
English: Lansoprazole is not significantly eliminated by haemodialysis.
Swedish: Hemodialys eliminerar inte lansoprazol i signifikant grad.
English: Eradication of H. pylori has been shown to be a definitive cure for duodenum ulcer and most gastric ulcers.
Swedish: Eradikering av Helicobacter pylori har visat sig vara en definitiv behandling vid sår i tolvfingertarmen och de flesta former av magsår.
English: CYP2C19 is subject to genetic polymorphism and 2-6% of the population, called poor metabolisers (PMs), are homozygote for a mutant CYP2C19 allele and therefore lacks a functional CYP2C19 enzyme.
Swedish: som kallas långsamma metaboliserare, är homozygoter för en muterad CYP2C19-allel och saknar därför ett funktionellt CYP2C19-enzym.
English: Sugar spheres (sucrose and maize starch) Sodium laurilsulphate Meglumine
Swedish: Kärna av socker (sackaros och majsstärkelse)
English: Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, toxicity to reproduction or genotoxicity.
Swedish: Gängse studier avseende allmäntoxicitet, upprepad dosering, reproduktionstoxikologiska effekter eller genotoxicitet visade inte några särskilda risker för människa.
English: 30 mg + 500 mg + 1000 mg twice daily for 5 days
Swedish: 30 mg + 500 mg + 1000 mg 2 gånger dagligen i 5 dagar
English: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Swedish: fruktosintolerans, glukos-galaktosmalabsorption eller sukras-isomaltasbrist.
English: Blood thrombocytopenia, eosinophilia, pancytopenia and agranulocytosis, anemia,
Swedish: pancytopeni och agranulocytos, anemi, leukopeni agranulocytos
English: Drugs which inhibits CYP3A4
Swedish: Läkemedel som hämmar CYP3A4
English: Lansoprazole has a similar mechanism of action to omeprazole and both increase gastric pH, the following statement is made by analogy to omeprazole.
Swedish: Lansoprazol och omeprazol har en likartad verkningsmekanism och båda höjer pH-värdet i ventrikeln.
English: Musculoskeletal and connective tissue disorders muscle and joint pain
Swedish: Muskuloskeletala systemet och bindväv muskel- och ledsmärta
English: Titanium dioxide (E 171) In addition for Lansoprazole 15 mg: Quinoline yellow (E 104) [To be completed nationally] 6.2.
Swedish: Kinolingult (E 104) [Fylls i lokalt] 6.2.
English: There is no need to change the dose in patients with impaired renal function.
Swedish: Nedsatt lever- eller njurfunktion: Dosen behöver inte ändras för patienter med nedsatt njurfunktion.
English: • Long-term prophylaxis of reflux oesophagitis.
Swedish: • Profylaktisk behandling av refluxesofagit.
English: Lansoprazole 15 mg:
Swedish: För Lansoprazol 15 mg dessutom:
English: 30 mg + 500 mg 3 times/day for 5 days
Swedish: 30 mg + 500 mg 3 gånger dagligen i 5 dagar
English: Coadministration of lansoprazole increases the plasma concentrations of tacrolimus (a CYP3A and P-gp substrate).
Swedish: Takrolimus Samtidig administrering av lansoprazol höjer plasmakoncentrationerna av takrolimus (ett CYP3A- och
English: 30 mg + 1000 mg 3 times/day for 5 days
Swedish: 30 mg + 1000 mg 3 gånger dagligen i 5 dagar
English: itraconazole, protease inhibitors, macrolides etc may markedly increase the plasma concentrations of lansoprazole.
Swedish: Läkemedel som hämmar CYP3A4, som ketokonazol, itrakonazol, proteashämmare, makrolider osv., kan påtagligt höja plasmakoncentrationerna av lansoprazol.
English: clarithromycin and either amoxycillin or metronidazole are the most widely accepted treatment for
Swedish: Trippelbehandlingar med en protonpumpshämmare, klaritromycin och endera amoxycillin eller metronidazol är den mest accepterade behandlingen av Helicobacter pylori-infektion.
English: Effect on gastric acid secretion: Lansoprazole is a specific inhibitor of the parietal cell proton pump.
Swedish: Lansoprazol är en specifik hämmare av parietalcellens protonpump.
English: Treatment of duodenal ulcer: The recommended dose is 30 mg once daily for 2 weeks.
Swedish: Behandling av refluxesofagit: Den rekommenderade dosen lansoprazol är 30 mg en gång om dagen i 4 veckor.
English: +/K +ATPase causing inhibition of the enzyme activity.
Swedish: ATPas och därigenom hämmar enzymaktiviteten.
English: Treatment of reflux oesophagitis:
Swedish: Profylaktisk behandling av refluxesofagit:
English: Pharmacokinetic Properties
Swedish: Farmakokinetiska uppgifter
English: Treatment of gastric ulcer:
Swedish: Behandling av duodenalsår:
English: Eradication of H. pyolori and peptic ulcer healing
Swedish: Eradikering av Helicobacter pylori och läkning av peptiskt magsår
English: hepatitis, icterus and interstitial nephritis.
Swedish: Lever och njurar förhöjda halter av leverenzymer hepatit, ikterus och interstitiell nefrit
English: Holder
Swedish: Styrka
English: Summary of Product Characteristics as set out in Annex III for Lansopon and associated names (see
Swedish: SKÄL FÖR ÄNDRING AV PRODUKTRESUMÉN CHMP har förordat att godkännande för försäljning beviljas, med ändringar i produktresumén i enlighet med bilaga III för Lansopon och synonymer (se bilaga 1) och med beaktande av följande:
English: ECL cell carcinoids associated with hypergastrinaemia due to inhibition of acid secretion and retinal atrophy.
Swedish: I två karcinogenicitetsstudier på råtta orsakade lansoprazol såväl dosrelaterad hyperplasi av ECL-celler som ECL-cellskarcinoider, associerade med hypergastrinemi på grund av hämning av syrasekretionen, samt retinal atrofi.
English: Johnson syndrome and toxic epidermal necrolysis.
Swedish: Blodet och lymfsystemet trombocytopeni,
English: leucopenia.
Swedish: genotyp.
English: petechia, purpura, hair loss, erythema multiforme, stevens
Swedish: Hud och subkutan vävnad eksem, urtikaria och klåda petekier, purpura, håravfall, erythema multiforme, Stevens-Johnsons syndrom och toxisk epidermal nekrolys.
English: CLINICAL PARTICULARS
Swedish: allmän sjukdomskänsla
English: • Treatment of reflux oesophagitis.
Swedish: • Behandling av refluxesofagit
English: Senses zaste disturbances and visual disturbances.
Swedish: Sinnesorganen smakrubbningar och synrubbningar
English: Cardiovascular peripheral edema,
Swedish: Magtarmkanalen illamående, diarré,
English: Tacrolimus
Swedish: Mannitol
English: If necessary, gastric emptying, charcoal and symptomatic therapy is recommended.
Swedish: Vid behov rekommenderas ventrikeltömning,
English: Uncommon
Swedish: Ej relevant
English: Investigations
Swedish: Biverkningar
English: Annex I).
Swedish: P-gp-substrat).
English: The recommended initial dose is 60 mg once daily.
Swedish: Den rekommenderade dosen är 30 mg en gång om dagen i 2 veckor.
English: However, the daily dose in the elderly should not exceed 30 mg.
Swedish: Dagsdosen för äldre patienter bör emellertid inte vara högre än 30 mg. Kapslarna skall sväljas hela med vätska.
English: The enzyme CYUP3A4
Swedish: Enzymet CYP3A4 bidrar också till metabolismen.
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, and marketing authorisation holders in the Member States
Swedish: Förteckning över läkemedlets namn, läkemedelsform, styrka, administreringssätt samt innehavare av godkännande för försäljning i medlemsstaterna
English: Nebido parenteral use
Swedish: Nebido parenteral användning
English: Denmark Eli Lilly Danmark A/S Lyskær 3E, 2.tv.
Swedish: Eli Lilly Danmark A/S Lyskær 3E, 2.tv.
English: Sweden Eli Lilly Sweden AB Box 721
Swedish: Eli Lilly Sweden AB Box 721
English: 169 27 Solna
Swedish: 169 27 Solna Sweden
English: 203 11 Malmö
Swedish: 203 11 Malmö Sweden
English: Ringener Str. 45
Swedish: KG Ringener Str. 45
English: Axxeron transdermal spray, solution
Swedish: Axxeron transdermal spray, lösning
English: Sweden Ferring Läkemedel AB Box 4041
Swedish: Ferring Läkemedel AB Box 4041
English: Germany MSD Sharp&Dohme Gesellschaft mit beschränkter Haftung Lindenplatz 1
Swedish: MSD Sharp&Dohme Gesellschaft mit beschränkter Haftung Lindenplatz 1
English: DK-2730 Herlev
Swedish: DK-2730 Herlev Denmark
English: capsules oral use
Swedish: kapsel oral användning
English: capsule, soft oral use
Swedish: kapsel, mjuk oral användning
English: Luxembourg Eli Lilly Benelux S.A. -N.V 1, rue du Marquis
Swedish: Luxemburg Eli Lilly Benelux S.A. -N.V 1, rue du Marquis
English: Bunsenstr.4
Swedish: Fabrikstr.7
English: N.V. Organon Postbus 20
Swedish: Organon Postbus 20
English: Germany Lilly Deutschland GmbH Teichweg 3
Swedish: Lilly Deutschland GmbH Teichweg 3
English: Polarisavenue 130 2132 JX Hoofddorp The Netherlands testosteron
Swedish: 2132 JX Hoofddorp The Netherlands testosteron
English: Luxembourg Ferring S.A. 93C, Capucienenlaan 9300 Aalst
Swedish: Luxemburg Ferring S.A. 93C, Capucienenlaan 9300 Aalst
English: Ferring-Léčiva, a.s.
Swedish: Slovakien Ferring-Léčiva, a.s.
English: 33611 Bielefeld
Swedish: 56 33611 Bielefeld Germany
English: 1000 Brussels
Swedish: 1000 Brussels Belgium
English: Germany Eifelfango ChemischPharmazeutische Wrke GmbH&Co.
Swedish: Eifelfango ChemischPharmazeutische Wrke GmbH&Co.
English: Germany Dr. August Wolff GmbH&Co.
Swedish: Dr. August Wolff GmbH&Co.
English: Merck Sharp & Dohme Limited
Swedish: Storbritannien Merck Sharp & Dohme Limited
English: Bayer House Strawberry Hill, Newbury RG14 1JA
Swedish: Strawberry Hill, Newbury RG14 1JA
English: Organon (Ireland) Limited PO Box 2857, Drynam Road, Swords Co. Dublin Ireland testosterone undecanoate Restandol Testocaps 40 mg capsules, soft oral use
Swedish: Organon (Ireland) Limited PO Box 2857, Drynam Road, Swords Co. Dublin Ireland testosterone undecanoate Restandol Testocaps 40 mg kapsel, mjuk oral användning
English: Alliance Pharmaceuticals Limited
Swedish: Storbritannien Alliance Pharmaceuticals Limited
English: Italy testosterone propionate
Swedish: Italy testosterone propionate TESTOVIS
English: Germany Jenapharm GmbH&CO.
Swedish: Jenapharm GmbH&CO.
English: Box 20
Swedish: Organon PO BOX 20
English: Axiron 30mg/1,5ml Lösung zur Anwendung auf der Haut solution
Swedish: Axiron 30mg/1,5ml Lösung zur Anwendung auf der Haut lösning
English: Belgium Ferring SA-NV Capucienenlaan 93C 9300 Aalst
Swedish: Ferring SA-NV Capucienenlaan 93C 9300 Aalst Belgium
English: Axiron cutaneous solution
Swedish: Axiron kutan lösning
English: Drayton Hall, Church Road West Drayton UB7 7PS United Kingdom
Swedish: Drayton Hall, Church Road West Drayton UB7
English: BAYER SANTE 220, avenue de la Recherche 59120 Loos France testosterone undecanoate NEBIDO 1000 mg/4 ml, solution injectable
Swedish: BAYER SANTE 220, avenue de la Recherche 59120 Loos France testosterone undecanoate NEBIDO 1000 mg/4 ml, solution injectable lösning
English: Nebido 250 mg/ml oldatos injekció intramuscular injection
Swedish: Nebido 250 mg/ml oldatos injekció intramuskulär injektion
English: 79111 Freiburg
Swedish: Jechtlinger Str. 13 79111 Freiburg Germany
English: Belgium Bayer SA-NV Jan Emiel Mommaertslaan
Swedish: Bayer SA-NV Jan Emiel
English: Bayer Pharma AG Müllerstr.
Swedish: Slovakien Bayer Pharma AG Müllerstr.
English: Axxeron cutaneous solution
Swedish: Axxeron kutan lösning
English: Ferring B.V.
Swedish: Nederländerna Ferring B.V.
English: Via S. Anna, 2 03012 Anagni Frosinone Italy testosterone enanthate
Swedish: Via S. Anna, 2 03012 Anagni Frosinone Italy testosterone enanthate TESTO ENANT
English: 22,5 mg/patch patch
Swedish: 22,5 mg/patch plåster
English: Ferring Ellas Farmakeytiki MEPE
Swedish: Ferring Ellas Farmakeytiki MEPE Gyzi 3
English: FERRING Pharmaceuticals CZ s.r.o.
Swedish: Pharmaceuticals CZ s.r.o.
English: cutaneous solution
Swedish: kutan lösning
English: GEYMONAT S.P.A., Via S. Anna, 2 03012 Anagni Frosinone Italy testosterone enanthate
Swedish: GEYMONAT S.P.A., Via S. Anna, 2 03012 Anagni Frosinone Italy testosterone enanthate TESTO ENANT
English: ANDROTARDYL 250 mg/1 ml, solution injectable intramusculaire solution
Swedish: ANDROTARDYL 250 mg/1 ml, solution injectable intramusculaire lösning
English: Ferring Pharmaceuticals Limited
Swedish: Storbritannien Ferring Pharmaceuticals Limited
English: Andriol Testocaps, 40 mg capsules capsule, soft oral use
Swedish: Andriol Testocaps, 40 mg capsules kapsel, mjuk oral användning
English: 92400 Courbevoie France testosterone undecanoate PANTESTONE 40 mg, capsule molle capsule, soft oral use
Swedish: 92400 Courbevoie France testosterone undecanoate PANTESTONE 40 mg, capsule molle kapsel, mjuk oral användning
English: AGOVIRIN DEPOT 5 mg/2 ml suspension for injection
Swedish: AGOVIRIN DEPOT 5 mg/2 ml injektionsvätska, suspension
English: 35396 Gießen
Swedish: 35396 Gießen Germany
English: Germany GALENpharm GmbH Wittland13
Swedish: GALENpharm GmbH Wittland13
English: Belgium Aspen Pharma Trading Limited, 3016 Lake Drive Citywest Business Campus Dublin 24
Swedish: Aspen Pharma Trading Limited, 3016 Lake Drive Citywest Business Campus Dublin 24
English: Ferring GmbH Wittland 11 + Kiel D-24109
Swedish: Bulgarien Ferring GmbH Wittland 11 + Kiel D-24109
English: 3016 Lake Drive Citywest Business Campus Dublin 24
Swedish: 3016 Lake Drive Citywest Business Campus
English: N.V. Organon PO BOX 20
Swedish: ORGANON P.O. Box 20
English: Lithuania Ferring Lääkkeet Oy PL 23
Swedish: Ferring Lääkkeet Oy PL 23
English: Sweden Laboratoires Besins International
Swedish: Nederländerna Laboratoires Besins International
English: Viale Certosa, 130 20156 Milano Italy testosterone enanthate
Swedish: Viale Certosa, 130 20156 Milano Italy testosterone enanthate TESTOVIRON
English: 5340 BH Oss The Netherlands testosterone undecanoate Andriol Testocaps 40 mg lágy kapszula capsule, soft oral use
Swedish: 5340 BH Oss The Netherlands testosterone undecanoate Andriol Testocaps 40 mg lágy kapszula kapsel, mjuk oral användning
English: Testogel cutaneous transdermal use
Swedish: Testogel kutan transdermal användning
English: 13353 Berlin Germany
Swedish: 13353 Berlin
English: Belgium Besins Healthcare Avenue Louise 287
Swedish: Besins Healthcare Avenue Louise 287 1050 Brussels Belgium
English: The Netherlands testosterone undecanoate Testocaps capsule, soft oral use
Swedish: The Netherlands testosterone undecanoate Testocaps kapsel, mjuk oral användning
English: 30 mg/patch patch
Swedish: 30 mg/patch plåster
English: DE-13342 Berlin
Swedish: D-13353 Berlin
English: Luxembourg Bayer S.A.-N.V. 14, J.E.Mommaerstlaan 1831 Diegem (Machelen) Belgium testosterone undecanoate Nebido
Swedish: 14, J.E.Mommaerstlaan 1831 Diegem (Machelen) Belgium testosterone undecanoate Nebido
English: Germany Laboratoires Besins international
Swedish: Rumänien LABORATOIRES BESINS INTERNATIONAL
English: DHP Healthcare Limited 26 Pickering Street Maidstone, Kent ME15 9RS
Swedish: Storbritannien DHP Healthcare Limited 26 Pickering Street
English: 15 mg/patch patch
Swedish: 15 mg/patch plåster
English: N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands testosterone propionate testosterone phenylpropionate testosterone isocaproate testosterone decanoate
Swedish: Organon Kloosterstraat 6 5349 AB Oss The Netherlands testosterone propionate testosterone phenylpropionate testosterone isocaproate testosterone decanoate
English: Ferring GmbH Wittland 11
Swedish: Slovenien Ferring GmbH Wittland 11
English: Testim cutaneous and transdermal preparations
Swedish: Testim kutana och transdermala beredningar
English: 25 mg/ml 2,5 mg/ml suspension for injection
Swedish: 25 mg/ml 2,5 mg/ml injektionsvätska, suspension
English: Testim cutaneous transdermal use
Swedish: Testim kutan transdermal användning
English: Germany Rotexmedica GmbH Arzneimittelwerk
Swedish: Rotexmedica GmbH Arzneimittelwerk Bunsenstr.4
English: Germany Pierre Faber Pharma GmbH Jechtlinger Str. 13
Swedish: Pierre Faber Pharma GmbH
English: 2,5 mg/25 mg/ ml suspension for injection
Swedish: 2,5 mg/25 mg/ ml injektionsvätska, suspension
English: Denmark Ferring Lægemidler A/S, Kay Fiskers Plads 11
Swedish: Ferring Lægemidler A/S, Kay Fiskers Plads 11 DK-2300 København S Denmark
English: Lithuania Bayer Pharma AG Mullerstrasse 178
Swedish: Bulgarien Bayer Pharma AG Müllerstraße 178
English: Tostrex cutaneous and transdermal preparations
Swedish: Tostrex kutana och transdermala beredningar
English: Luxembourg Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business
Swedish: Luxemburg Aspen Pharma Trading Limited, 3016 Lake
English: Bayer Austria GmbH Herbststrasse 6-10 1160 Wien Austria testosterone undecanoat
Swedish: Bayer Austria GmbH Herbststrasse 6-10 1160 Wien Austria testosterone undecanoat Nebido 1000 mg/4 ml Injektionslösung
English: Axiron cutaneous solution cutaneous and transdermal preparations
Swedish: Axiron kutan lösning kutana och transdermala beredningar
English: Pod Višňovkou 1662/21 14000 Praha 4
Swedish: Pod Višňovkou 1662/21
English: Lithuania N.V. ORGANON P.O.
Swedish: Slovakien N.V.
English: Luxembourg Prostrakan Ltd Galabank Business Park Galashiels
Swedish: Luxemburg Prostrakan Ltd Galabank Business Park Galashiels
English: Ireland testosterone undecanoate Nebido 1000 mg/4ml, solution for injection intramuscular
Swedish: Ireland testosterone undecanoate Nebido 1000 mg/4ml, solution for injection intramuskulär